Personal information

No personal information available

Activities

Collapse all

Employment (1)

ACT Genomics: Hong Kong, HK

Employment
Source: Self-asserted source
Nina

Works (9)

Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab

Case Reports in Oncological Medicine
2020-03-02 | Journal article
DOI: 10.1155/2020/9072173
Part of ISSN: 2090-6706
Part of ISSN: 2090-6714
Source: Self-asserted source
Nina

Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer

Case Reports in Oncological Medicine
2019-09-10 | Journal article
DOI: 10.1155/2019/6545298
Part of ISSN: 2090-6706
Part of ISSN: 2090-6714
Source: Self-asserted source
Nina

TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer

Cancers
2019-07-30 | Journal article
DOI: 10.3390/cancers11081079
Part of ISSN: 2072-6694
Source: Self-asserted source
Nina

Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer

Molecular Cancer Therapeutics
2018-10 | Journal article
DOI: 10.1158/1535-7163.mct-17-1306
Part of ISSN: 1535-7163
Part of ISSN: 1538-8514
Source: Self-asserted source
Nina

PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients

Cancers
2018-09-06 | Journal article
DOI: 10.3390/cancers10090314
Part of ISSN: 2072-6694
Source: Self-asserted source
Nina

Pazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplification

Journal of the National Comprehensive Cancer Network
2017-12 | Journal article
DOI: 10.6004/jnccn.2017.7030
Part of ISSN: 1540-1405
Part of ISSN: 1540-1413
Source: Self-asserted source
Nina

Prevalence and clinical significance of <i>BRCA1/2</i> germline and somatic mutations in Taiwanese patients with ovarian cancer

Oncotarget
2016-12-20 | Journal article
DOI: 10.18632/oncotarget.13456
Part of ISSN: 1949-2553
Source: Self-asserted source
Nina

Missense mutations in the <i>TP53</i> DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma

Oncotarget
2016-07-12 | Journal article
DOI: 10.18632/oncotarget.9925
Part of ISSN: 1949-2553
Source: Self-asserted source
Nina

The application of anti-Toso antibody enhances CD8+ T cell responses in experimental malaria vaccination and disease

Vaccine
2015-11 | Journal article
DOI: 10.1016/j.vaccine.2015.10.065
Part of ISSN: 0264-410X
Source: Self-asserted source
Nina
How many people are using ORCID?